Clinical Trial Update: Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas. [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety of intensity-modulated radiotherapy with an inhomogeneous dose in patients with relapsed high-grade gliomas, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Glioblastoma Multiforme, Glioblastoma | NA | Status: COMPLETED